Safety and efficacy of sirolimus in recurrent intravenous leiomyomatosis, pulmonary benign metastatic leiomyomatosis, and leiomyomatosis peritonealis disseminata: a pilot study

Abstract Background Intravenous leiomyomatosis (IVL), pulmonary benign metastatic leiomyomatosis (PBML), and leiomyomatosis peritonealis disseminata (LPD) are leiomyomas with special growth patterns and high postoperative recurrence rates. We report the safety and efficacy of a pilot study of siroli...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Guorui Zhang, Rong Fan, Hua Yang, Hao Su, Xin Yu, Yutong Wang, Fengzhi Feng, Lan Zhu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2024-03-01
Rangatū:	BMC Medicine
Ngā marau:	Sirolimus mTOR inhibitor Intravenous leiomyomatosis Pulmonary benign metastatic leiomyomatosis Leiomyomatosis peritonealis disseminata
Urunga tuihono:	https://doi.org/10.1186/s12916-024-03344-9
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!